pargyline has been researched along with Encephalopathy, Hepatic in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsasua, A | 1 |
| Arias, J | 1 |
| López-Sánchez, ML | 1 |
| Estébanez, E | 1 |
| Arias, JI | 1 |
| García de Jalón, PD | 1 |
| Durán Sacristán, H | 1 |
| Zieve, L | 1 |
| Olsen, RL | 1 |
2 other studies available for pargyline and Encephalopathy, Hepatic
| Article | Year |
|---|---|
[Concentration of biogenic amines in the central and peripheral nervous systems of rats with portacaval shunts, and their changes following administration of pargyline and levodopa].
Topics: Animals; Biogenic Amines; Brain Chemistry; Hepatic Encephalopathy; Levodopa; Male; Pargyline; Periph | 1982 |
Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?
Topics: Animals; Brain Chemistry; Dopamine; Hepatic Encephalopathy; Male; Norepinephrine; Octopamine; Pargyl | 1977 |